Harmonic Pharma's core business is directed towards identifying and characterizing new chemical entities (NCE), and repurposing clinical or approved drugs in four main therapeutic areas: Alzheimer disease, Infectious diseases, Diabetes associated diseases, and Cancer.
Therapeutic Potential
French Awards for Innovation (2008 and 2009)
CAPRI rounds 1-17, international blind docking trials; use of spherical harmonics (Proteins 2003)
Community-wide assessment of GPCR structure modelling and docking (Nature Reviews Drug Discovery 2009)
CAPRI rounds 1-17, international blind docking trials; use of spherical harmonics (Proteins 2003)
Community-wide assessment of GPCR structure modelling and docking (Nature Reviews Drug Discovery 2009)
Harmonic Pharma
Espace Transfert
615, rue du Jardin Botanique
54600 Villers-lès-Nancy - France
Tél. : + 33 (0)3 54 95 86 04
www.harmonicpharma.com
